Development and Manufacture of Pharmaceutical Dosage Forms for Treatment of Substance Abuse Disorders 75N98026R00007SB
Summary
AI-generated · Feb 18, 2026Develop and manufacture pharmaceutical dosage forms for use in NIDA’s medications development program targeting substance use disorders, including formulation development, manufacturing, quality control testing, stability studies, and distribution of drug products for use in preclinical and clinical studies. Some candidate treatments being investigated are new chemical entities and previously approved drug substances.
The government sources these drug substances from private industry, government contractors/grantees, or independent investigators. This effort provides a centralized resource for end-to-end development and manufacture of dosage forms to support preclinical and clinical testing.
The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified organizations having the capability to carry out development of formulations, manufacture, quality control tests, stability studies and distribution of pharmaceutical drug products to be used in the medications development program for treating substance use disorders. Development of medications for the treatment of substance use disorders is a major mission of NIDA. Some of the potential treatment drugs currently being investigated are new chemical entities and previously approved drug substances. The Government acquires these drug substances from private industries, Government contractors/grantees, or independent investigators. This contract is to provide the Government a resource for the development and manufacture of pharmaceutical dosage forms for use in preclinical and clinical studies. Please see SSN attached.
From Sources Sought posted on Feb 17, 2026Notice history
1-
Sources Sought LATEST Posted Feb 17, 2026
Details
Award Information
Not yet awarded
Contacts
Phone
Phone
Agency
Place of Performance
USA